About Sitagliptin Phosphate API
| Composition |
Sitagliptin
|
| Manufacturer |
Cerata Pharmaceuticals LLP
|
| Form |
Powder
|
| CAS |
486460-32-6
|
| Type |
API Powder
|
| Therapeutic Use |
Anti Diabetic
|
Product Information :
Product Name :iSitagliptin Phosphate API
Grade :iIP/BP/USP/IH (Pharma Grade)
Manufacturer :iCerata Pharmaceuticals LLP
Packaging :iHDPE Drum
Shelf Life :i5 years
API Form :iPowder
Country Of Origin :iIndia
Superior API for Diabetes TreatmentSitagliptin Phosphate acts as a potent anti-diabetic agent, specifically tailored for the management of type 2 diabetes mellitus. Its high assay value (99.0% by HPLC) and minimal impurity profile ensure it is suitable for pharmaceutical formulations demanding the utmost quality, efficacy, and patient safety.
Compliant With International Quality StandardsThis API is produced adhering to global regulatory standards, meeting pharmacopoeial thresholds for microbial load, loss on drying, heavy metals, and residual solvents. Each batch undergoes identification by IR and HPLC, ensuring authenticity. Its packaging preserves stability by protecting against moisture and light.
Flexible Supply, Reliable SourcingAs a trusted exporter, importer, manufacturer, and supplier from India, we offer Sitagliptin Phosphate in 10kg and 25kg drums, catering to varied production needs. Our robust logistics network and bulk packaging optimize the procurement process for clients worldwide.
FAQ's of Sitagliptin Phosphate API:
Q: How should Sitagliptin Phosphate API be stored for optimal stability?
A: Sitagliptin Phosphate API should be stored below 25C, protected from light and moisture, to maintain its chemical integrity and shelf life. Proper storage conditions help ensure the product remains within specification for up to 36 months.
Q: What is the primary benefit of using Sitagliptin Phosphate API in pharmaceutical formulations?
A: The chief benefit is its high assay purity (99.0%) and consistent quality, which result in effective and safe anti-diabetic medications for treating type 2 diabetes mellitus. This ensures patients receive reliable therapy.
Q: When is it appropriate to select Sitagliptin Phosphate Monohydrate for product development?
A: This API is ideal for development when robust regulatory compliance, low impurity content (total 0.5%), and proven efficacy in diabetes management are required. It suits manufacturers seeking high-quality bulk ingredients.
Q: Where is Sitagliptin Phosphate API typically sourced from?
A: Our Sitagliptin Phosphate is manufactured and exported from India, ensuring compliance with international quality standards. We serve global clients as a leading supplier, exporter, importer, and manufacturer.
Q: What identification and quality checks are performed on Sitagliptin Phosphate?
A: Each batch is identified and verified by IR and HPLC methods, and tested for properties such as specific rotation, assay, related substances, heavy metal content, microbial limits, and residual solvents in line with pharmacopeial and ICH guidelines.
Q: How is the API packaged and supplied to manufacturers?
A: The API is securely packaged in fiber drums lined with double PE bags, available in net weights of 10kg and 25kg. This ensures safe handling, storage, and transportation to maintain product efficacy.
Q: What are the usage instructions and safety profile of Sitagliptin Phosphate?
A: This API is intended for formulation into oral medicines for type 2 diabetes. It is odorless and bitter, non-poisonous at prescribed dosages, and should be handled following pharmaceutical manufacturing protocols to ensure worker safety and product integrity.